Institute of Biomedicine

Contact Details

Persons

  

  

  

1 of 31

  

  

  

---

• Aaltonen, Virpi
• Aatsinki, Milla
• Abbas, Hyder
• Abdelkawy, Yara
• Abe, Oluwatosin
• Abid, Tazrian
• Abouguendia, Hatem
• Abuasaker, Baraa
• Adamsson, Annika
• Afshan, Syeda
• Ahmedani, Ammar
• Ahmed, Nisar
• Ahramo, Kaisa
• Airaksinen, Jenni
• Åkerfelt, Malin
• Akram, Sadia
• Alanne, Erika
• Ali, Aliaa
• Alinikula, Jukka
• Alipour, Maedeh

Publications

  

  

  

83 of 521

  

  

  

---

• Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study  (2019)
• Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children  (2023)
• Circulating metabolites in progression to islet autoimmunity and type 1 diabetes  (2019)
• Circulating N-Acetylaspartate does not track brain NAA concentrations, cognitive function or features of small vessel disease in humans  (2022)
• Circulating oxidized LDL lipids, when proportioned to HDL-c, emerged as a risk factor of all-cause mortality in a population-based survival study  (2013)
• Circulating oxylipin and bile acid profiles of dexmedetomidine, propofol, sevoflurane, and S-ketamine : a randomised controlled trial using tandem mass spectrometry  (2022)
• Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinoma  (2023)
• Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET/CT  (2023)
• Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study  (2017)
• Circulating β cell-specific CD8+ T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes  (2020)